Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OMIWX
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
BA-1301
|
|||||
| Synonyms |
BA 1301; BA-1301; BA1301; Claudin 18.2 ADC-Shandong Boan Biotechnology; PR 301; PR301
Click to Show/Hide
|
|||||
| Organization |
Shandong Boan Biological Technology Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Claudin-18.2 (CLDN18.2)
|
Antigen Info | ||||
| Payload Name |
Duostatin 5
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
